isabelobrien, Author at European Medical Journal - Page 38 of 68

European Commission gives green light to Roche’s PNH treatment

Roche has secured European Commission approval for its drug crovalimab, marking a significant advancement in the treatment of PNH.

Bavarian Nordic to manufacture 440,000 doses of mpox vaccine

Bavarian Nordic has entered into a significant agreement to manufacture 440,000 additional doses of its vaccine in response to the escalating mpox outbreak.

NHS must adapt for next wave of advanced therapies, warns ABPI

The NHS has made commendable progress in introducing advanced therapies, but it must accelerate preparations for the next wave.

Meeting the growing demand for medical education quizzes

If you want to engage HCPs, you must deliver high-quality medical education. But are all companies taking advantage of interactive quizzes?

Orange lungs on yellow background

J&J wins FDA approval for chemo-free treatment for lung cancer

The FDA has approved Johnson & Johnson’s new chemotherapy-free combination treatment for patients with non-small cell lung cancer.

Vaccines on blue background

WHO makes urgent call to companies developing mpox vaccines

The World Health Organization has made an urgent call to pharmaceutical companies producing mpox vaccines to submit a Expressions of Interest for Emergency Use Listing (EUL).

MHRA signs off on Astellas' gastric cancer treatment

Astellas Pharma has received approval from the UK’s MHRA for its innovative therapy designed to treat gastric cancer.

FDA nod for world's first needle-free allergic reaction treatment

The FDA has granted approval for an innovative epinephrine nasal spray, making it the first needle-free emergency treatment for potentially fatal allergic reactions.

Upgrading the US congress customer experience

A US congress is the place to put your drug on the map, but is this landscape the home of great customer experience for HCPs?

Astellas’ Tadaaki Taniguchi on how to challenge the status quo

In this season finale of the podcast, Isabel speaks to Dr Tadaaki Taniguchi, Chief Medical Officer, Head of Medical and Development, Astellas Pharma.